Dr Mark Peterzan is an ST6 trainee based in South London. He completed a DPhil investigating creatine kinase kinetics in the hearts of patients with severe valvular heart disease and in athletic remodelling at the Oxford Centre for Clinical Magnetic Resonance Research (John Radcliffe Hospital, Oxford), and plans to train in imaging and heart failure.
Articles by Mark Peterzan
- What have we learned from DAPA-HF? ( 01/12/2019 )
- What is preserved LV ejection fraction in aortic stenosis: 0.50, 0.55 or 0.60? ( 31/01/2019 )
- TAVR in low risk severe AS has landed: what remains uncertain? ( 12/04/2019 )
- Screening for cardiac amyloidosis in severe aortic stenosis ( 03/05/2020 )